Results for tag: "Odactra"

The Odactra market is a subset of the larger allergy drug market, which is composed of pharmaceuticals and biologics used to treat allergic reactions. Odactra is a sublingual immunotherapy (SLIT) drug, which is administered orally and works by gradually desensitizing the body to allergens. It is a long-term treatment option for those with allergies, and is often used in conjunction with other medications. Odactra is typically prescribed for those with moderate to severe allergies, and is available in both tablet and liquid form. The Odactra market is highly competitive, with many companies offering similar products. Some of the major players in the market include Merck, ALK-Abello, Stallergenes Greer, and Allergy Therapeutics. These companies are all involved in the research, development, and marketing of Odactra and other SLIT drugs. Show Less Read more